Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature

Metastatic pheochromocytoma and paraganglioma (PPGL) are rare diseases with dismal prognosis and standard therapies are lacking. We herein report the first case of a germline anaplastic lymphoma kinase (ALK) mutation in a patient with chemorefractory metastatic pheochromocytoma in the absence of mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Heregger, R., Huemer, F., Hutarew, G., Hecht, S., Cheveresan, L., Kotzot, D., Schamschula, E., Rinnerthaler, G., Melchardt, T., Weiss, L., Greil, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358412/
https://www.ncbi.nlm.nih.gov/pubmed/34371380
http://dx.doi.org/10.1016/j.esmoop.2021.100233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358412/
https://www.ncbi.nlm.nih.gov/pubmed/34371380
http://dx.doi.org/10.1016/j.esmoop.2021.100233

Ejemplares similares